Cara Therapeutics Inc (CARA)
0.2756
0.00 (0.00%)
USD |
NASDAQ |
Oct 04, 16:00
0.271
0.00 (0.00%)
After-Hours: 20:00
Cara Therapeutics Shareholders Equity (Annual): 57.08M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 57.08M |
| December 31, 2022 | 158.78M |
| December 31, 2021 | 227.52M |
| December 31, 2020 | 249.00M |
| December 31, 2019 | 186.71M |
| December 31, 2018 | 133.63M |
| December 31, 2017 | 86.78M |
| Date | Value |
|---|---|
| December 31, 2016 | 50.72M |
| December 31, 2015 | 105.04M |
| December 31, 2014 | 51.66M |
| December 31, 2013 | 11.51M |
| December 31, 2012 | 2.439M |
| December 31, 2011 | 6.104M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
57.08M
Minimum
2023
249.00M
Maximum
2020
175.82M
Average
186.71M
Median
2019
Shareholders Equity (Annual) Benchmarks
| Perspective Therapeutics Inc | 75.18M |
| Alaunos Therapeutics Inc | 6.307M |
| Seelos Therapeutics Inc | -33.51M |
| Oragenics Inc | 3.168M |
| Cocrystal Pharma Inc | 26.38M |